Market News

Utz Q3 2026 results miss estimates as sales and margins fall; investors focus on pending $14.25-per-share Intersnack take-private deal.

Barclays analyst David Anderson maintains Ormat Technologies (NYSE:ORA) with a Overweight and lowers the price target from $122 to $113.

SANTA CLARA, Calif., November 06, 2026--Oklo Inc. (NYSE: OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today announced a st...

PPL Corporation (NYSE: PPL) today announced third-quarter 2026 reported earnings (GAAP) of $367 million, or $0.49 per share, compared with third-quart...

Tesla is saying goodbye to the Cybertruck. Here's a look back at the vehicle's history and how much the stock has gained since the EV was unve...

https://www.cnbc.com/2026/11/06/open-ai-data-centers-election.html

Capitulation Criteria  Please click here for an enlarged chart of Direxion Daily Semiconductor Bull 3X ETF (NYSE:SOXL). Note the following: ...

Barclays analyst Raimo Lenschow maintains Open Text (NASDAQ:OTEX) with a Equal-Weight and raises the price target from $27 to $29.

Moderna Q3 revenue and EPS beat consensus, swung to profit, raised 2026 revenue guidance, and shares rose 7.9% premarket on strong results.

Castellum (AMEX:CTM) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provid...

MA's Q3 services revenues jump 19% and adjusted EPS rises 21.2%, but rising incentives and a premium valuation raise questions about buying shares now...

Investing.com - U.S. stock futures pointed to a mixed open on Friday as chip stocks rebounded following a broad-based selloff in the previous session,...

Barclays analyst William Grippin maintains Onterris (NYSE:ONT) with a Equal-Weight and raises the price target from $15 to $19.

InTest Q3 2026 EPS beat on strong margins; record $49.4M orders and $59.7M backlog signal 2027 growth despite slight revenue miss and soft Q4 guide.

NEW YORK (AP) — NEW YORK (AP) — Brookfield Asset Management Ltd. (BAM) on Friday reported third-quarter earnings of $2.

Key TakeawaysSpotify (SPOT:NYSE) stock is up 7% in the past week, mostly after a report that it plans a paid AI remix and cover service for early 2027...

Humana's mixed Q3 2026 results met revenue views, adjusted loss was narrower, and FY adjusted EPS guidance rose, though shares dipped premarket.

Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $24 to $22.

Beyond Meat continues to face deteriorating fundamentals, with Q3 revenues down 8.1% year-over-year. Read more on BYND stock here.

Guggenheim analyst Michael Schmidt reiterates Enliven Therapeutics (NASDAQ:ELVN) with a Buy and maintains $78 price target.